CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 249 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is 2.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $322,418 | -25.8% | 3,197 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $434,441 | +30.4% | 3,197 | -0.4% | 0.02% | +23.1% |
| Q1 2023 | $333,287 | +17.2% | 3,209 | 0.0% | 0.01% | +18.2% |
| Q4 2022 | $284,446 | +10.7% | 3,209 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $257,000 | -16.3% | 3,209 | 0.0% | 0.01% | -15.4% |
| Q2 2022 | $307,000 | -35.9% | 3,209 | -0.5% | 0.01% | -27.8% |
| Q1 2022 | $479,000 | +4.8% | 3,225 | 0.0% | 0.02% | +5.9% |
| Q4 2021 | $457,000 | +8.3% | 3,225 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $422,000 | -4.7% | 3,225 | 0.0% | 0.02% | -5.6% |
| Q2 2021 | $443,000 | +4.7% | 3,225 | -0.3% | 0.02% | -5.3% |
| Q1 2021 | $423,000 | +16.9% | 3,236 | 0.0% | 0.02% | +18.8% |
| Q4 2020 | $362,000 | +42.0% | 3,236 | 0.0% | 0.02% | +33.3% |
| Q3 2020 | $255,000 | +9.4% | 3,236 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $233,000 | +24.6% | 3,236 | -0.9% | 0.01% | +8.3% |
| Q1 2020 | $187,000 | -48.3% | 3,266 | +0.9% | 0.01% | -40.0% |
| Q4 2019 | $362,000 | – | 3,236 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |